Susquehanna International Group’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,078
Closed -$30.5K 13510
2023
Q3
$30.5K Sell
19,078
-30,594
-62% -$84.5K ﹤0.01% 11479
2023
Q2
$145K Buy
+49,672
New +$113K ﹤0.01% 10611
2023
Q1
Sell
-21,891
Closed -$60.7K 13703
2022
Q4
$40.9K Sell
21,891
-1,070
-5% -$1.67K ﹤0.01% 11501
2022
Q3
$29K Buy
+22,961
New +$50K ﹤0.01% 12462
2021
Q4
Sell
-23,434
Closed -$469K 14097
2021
Q3
$470K Sell
23,434
-2,725
-10% -$70.3K ﹤0.01% 9548
2021
Q2
$807K Buy
+26,159
New +$783K ﹤0.01% 8352

Other funds holding RNLX

Susquehanna International Group's RNLX Position: Q4 2023 in Review

Susquehanna International Group sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2023, closing a stake of 19,078 shares — an estimated $30.5K sold.

Susquehanna International Group first reported a position in RNLX in Q2 2021 and held it in 6 quarters. The position peaked at $807K in Q2 2021. 27 funds tracked by Wall St. Rank hold RNLX as of Q4 2023.

  • Susquehanna International Group reported no remaining Renalytix plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 19,078 Renalytix plc American Depositary Shares shares in Q4 2023, an estimated $30.5K.
  • Susquehanna International Group first reported a position in Renalytix plc American Depositary Shares in Q2 2021 and held it in 6 quarters.
  • Susquehanna International Group's Renalytix plc American Depositary Shares position peaked at $807K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.